QA: Arcus Biosciences Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001724521_2026_Arcus_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0001724521, Arcus Biosciences Inc

  xvar xval
0 AssetsCurrent 1,007,000,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 40,000,000
3 remainder_Assets 92,000,000
4 LiabilitiesCurrent 231,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 80,178,625
9 ResearchAndDevelopmentExpense 773,066,720
10 remainder_Expenses 19,047,906
11 remainder_Revenues 249,822,592
12 remainder_NetIncome 21,038,988
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,139,000,000
1 Liabilities 231,000,000
2 Expenses 872,293,251
3 Revenues 249,822,592
4 StockholdersEquity 908,000,000
5 NetIncome -601,431,671
6 ComprehensiveNetIncome -601,431,671
7 BaseVar 1,256,577,416
8 EconomicCapitalRatiobeforeLimitedLiability 2.01
9 EconomicCapitalRatio 3.03

Edgar->Model Mapping

Feature Distribution

Change over Time